Scientists make strides toward male birth control; fentanyl is making it harder to start addiction treatment

Scientists have promised that a male birth control drug is a decade away since at least the 1970s. Will it finally become a reality? ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

Sponsored by      After decades of setbacks, scientists make strides toward the holy grail of male birth control By Eleanor Cummins Maria Fabrizio for STAT Researchers aim to usher in a new vision of what feminist bioethicist Lisa Campo-Engelstein has called "contraceptive justice." Read More Fentanyl isn't just causing overdoses. It's making it harder to start addiction treatment By Lev Facher Elise Amendola/AP The synthetic opioid appears more likely to cause severe withdrawal symptoms for patients put on buprenorphine for treatment. Read More STAT+: Thrive founders launch new blood testing startup to spot when cancer returns By Allison DeAngelis Adobe Cancer patients often worry whether the disease will return. A new test that searches blood for traces of cancer DNA could offer answers. Read More Sponsored Insight by NOVAVAX How is Novavax taking a global approach to immunization? Novavax is a biotechnology company solely devoted to innovating vaccine technology and setting the world up for success in immunization. Investigational vaccines built on the Novavax platform can be efficiently produced and scaled to meet global demand. Learn more. Cerebral's CEO responds to concerns about prescribing pressures and telehealth safety By Katie Palmer STAT Cerebral saw explosive growth early in the pandemic, but 2022 has brought a spate of challenges for the mental health care company. Read More STAT+: Lilly CEO concedes Twitter flap over insulin costs shows there's 'more work to do' By Ed Silverman Adobe After a fake tweet claimed Lilly would give insulin away for free, the drugmaker' CEO acknowledged the need to expand access. Read More The scientist behind Pfizer's Covid vaccine says a flu pandemic is only a matter of time By Olivia Goldhill Vaccine researcher Kathrin Jansen says a flu pandemic is inevitable: "The question is, does it come tomorrow or 50 years from now?" Read More FDA formally warns companies behind Family Guy vapes, other illegal products marketed at kids By Nicholas Florko Alex Hogan/STAT The FDA is warning multiple companies they must stop selling vape products marketed to young people, including two that STAT highlighted. Read More Why doesn't the U.S. have more Black doctors? By Brittany Trang STAT The number of Black men accepted to medical school declined between 1978 and 2014, even though the number of available spots grew. Read More WHO, Uganda plan to test three candidate Ebola vaccines in outbreak By Helen Branswell Luke Dray/Getty Images The first doses of vaccine should arrive in Uganda next week, though the WHO has not yet indicated a start date for the trial. Read More Covid-19 vaccines were a success, but mRNA still has a delivery problem. Two startups have an unorthodox solution By Jonathan Wosen CHRISTOPHE ENA/POOL/AFP via Getty Images In cases where mRNA is harnessed for other uses — such as targeting a specific set of tumor cells — delivery won't be so straightforward. Read More Opinion: Listen: The 'First Opinion Podcast' live from Boston: Jay Baruch returns By Patrick Skerrett Emergency physician Jay Baruch penned a letter to his boss spelling out his intention to leave medicine behind. The aftermath surprised him. Read More Wednesday, November 16, 2022       1 Exchange Pl, Suite 201, Boston, MA 02109 ©2022, All Rights Reserved. I no longer wish to receive STAT emails Update Email Preferences | Contact Us | View In Browser